Foghorn Therapeutics Inc. (FHTX) Nonoperating Income (Expense) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Foghorn Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2024.
  • Foghorn Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $3.18 M, a 6.23% decline year-over-year.
  • Foghorn Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $13.5 M, a 25.5% increase year-over-year.
  • Foghorn Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $13.7 M, a 66% increase from 2022.
  • Foghorn Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $8.26 M.
  • Foghorn Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was -$586 K, a 118% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $13.5 M $3.18 M -$211 K -6.23% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $13.7 M $3.34 M +$338 K +11.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $13.4 M $3.47 M +$984 K +39.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $12.4 M $3.51 M +$1.63 M +86.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $10.8 M $3.39 M +$2.5 M +281% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $8.26 M $3 M +$4.06 M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $4.19 M $2.49 M +$2.31 M +1276% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $1.89 M $1.88 M +$1.73 M +1150% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $160 K $890 K +$746 K +518% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$586 K -$1.06 M -$1.08 M -5152% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $496 K $181 K +$59 K +48.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $437 K $150 K +$334 K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $103 K $144 K +$372 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$269 K $21 K Oct 1, 2020 Dec 31, 2020 10-K/A 2022-08-09
Q3 2020 $122 K +$114 K +1425% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$184 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$228 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $8 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.